A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: First line of the email MUST contain NCT # and Site #.
Study Contact Backup
- Name: BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
- Phone Number: 855-907-3286
- Email: Clinical.Trials@bms.com
Study Locations
-
-
-
Buenos Aires, Argentina, 1430
- Not yet recruiting
- Local Institution - 0346
-
Contact:
- Site 0346
-
Buenos Aires, Argentina, 1122
- Completed
- Local Institution - 0345
-
Buenos Aires, Argentina, 1426
- Active, not recruiting
- Local Institution - 0012
-
Buenos Aires, Argentina, 1426
- Active, not recruiting
- Local Institution - 0317
-
Mendoza, Argentina, 5500
- Completed
- Local Institution - 0348
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 1280
- Not yet recruiting
- Local Institution - 0011
-
Contact:
- Site 0011
-
-
Buenos Aires F.D.
-
ABB, Buenos Aires F.D., Argentina, 1181
- Completed
- Local Institution - 0214
-
-
Córdoba Province
-
Córdoba, Córdoba Province, Argentina, X5004BAL
- Active, not recruiting
- Local Institution - 0143
-
Río Cuarto, Córdoba Province, Argentina, X5800ALB
- Active, not recruiting
- Local Institution - 0137
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Active, not recruiting
- Local Institution - 0142
-
-
-
-
New South Wales
-
Macquarie University, New South Wales, Australia, 2109
- Active, not recruiting
- Local Institution - 0170
-
-
Queensland
-
Brisbane, Queensland, Australia, 4029
- Active, not recruiting
- Local Institution - 0035
-
-
Victoria
-
Ballarat Central, Victoria, Australia, 3350
- Active, not recruiting
- Local Institution - 0197
-
Heidelberg, Victoria, Australia, 3084
- Active, not recruiting
- Local Institution - 0031
-
Melbourne, Victoria, Australia, 3000
- Active, not recruiting
- Local Institution - 0274
-
-
Western Australia
-
Subiaco, Western Australia, Australia, 6008
- Completed
- Local Institution - 0028
-
-
-
-
-
Salzburg, Austria, 5020
- Active, not recruiting
- Local Institution - 0267
-
Sankt Pölten, Austria, 3100
- Active, not recruiting
- Local Institution - 0270
-
Vienna, Austria, 1090
- Active, not recruiting
- Local Institution - 0269
-
-
Styria
-
Graz, Styria, Austria, 8036
- Active, not recruiting
- Local Institution - 0292
-
-
Tyrol
-
Innsbruck, Tyrol, Austria, 6020
- Active, not recruiting
- Local Institution - 0268
-
-
-
-
-
Rio de Janeiro, Brazil, 20230-130
- Active, not recruiting
- Local Institution - 0153
-
São Paulo, Brazil, 01317-000
- Active, not recruiting
- Local Institution - 0144
-
São Paulo, Brazil, 01401-002
- Active, not recruiting
- Local Institution - 0149
-
-
Amazonas
-
Manaus, Amazonas, Brazil, 69020-030
- Withdrawn
- Local Institution - 0187
-
-
Ceará
-
Fortaleza, Ceará, Brazil, 60135-237
- Active, not recruiting
- Local Institution - 0147
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brazil, 29055450
- Completed
- Local Institution - 0157
-
-
Federal District
-
Lago Sul, Federal District, Brazil, 71681-603
- Withdrawn
- Local Institution - 1038
-
-
Paraná
-
Curitiba, Paraná, Brazil, 81480-580
- Completed
- Local Institution - 0159
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90470-340
- Completed
- Local Institution - 0199
-
-
São Paulo
-
Barretos, São Paulo, Brazil, 14784400
- Active, not recruiting
- Local Institution - 0148
-
São José do Rio Preto, São Paulo, Brazil, 15090000
- Active, not recruiting
- Local Institution - 0164
-
-
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 5L3
- Recruiting
- BC Cancer Kelowna
-
Contact:
- Susan Ellard, Site 0218
- Phone Number: +1250-712-3996
-
Victoria, British Columbia, Canada, V8R 6V5
- Withdrawn
- Local Institution - 0217
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- Recruiting
- The Ottawa Hospital - General Campus
-
Contact:
- Xinni Song, Site 0265
- Phone Number: 6137377700ext70208
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Recruiting
- McGill University Health Centre
-
Contact:
- Jamil Asselah, Site 0219
- Phone Number: 514934193435721
-
Montreal, Quebec, Canada, H2X 3E4
- Recruiting
- Centre Hospitalier de l'Université de Montréal
-
Contact:
- Danielle Charpentier, Site 0215
- Phone Number: 5148908000
-
Saint-Charles-Borromée, Quebec, Canada, J6E 6J2
- Recruiting
- Centre Intégré de Santé et de Services Sociaux de Lanaudière
-
Contact:
- Angélique Brunot, Site 0350
- Phone Number: 579-593-1172
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Recruiting
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUS
-
Contact:
- Michel Pavic, Site 0216
- Phone Number: 819-346-1110x74816
-
-
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 7500921
- Completed
- Local Institution - 0138
-
Santiago, Santiago Metropolitan, Chile, 7650568
- Active, not recruiting
- Local Institution - 0021
-
Santiago, Santiago Metropolitan, Chile, 8330032
- Active, not recruiting
- Local Institution - 0017
-
Santiago, Santiago Metropolitan, Chile, 8420383
- Active, not recruiting
- Local Institution - 0018
-
-
Valparaiso
-
Viña del Mar, Valparaiso, Chile, 2520598
- Completed
- Local Institution - 0016
-
-
-
-
-
Guangzhou, China, 510060
- Recruiting
- Sun Yat-sen University Cancer Center
-
Contact:
- Shusen Wang, Site 1025
- Phone Number: 8613926168469
-
-
Anhui
-
Hefei, Anhui, China, 230001
- Recruiting
- Anhui Provincial Hospital
-
Contact:
- Nannan Lu, Site 1002
- Phone Number: 8618130056850
-
Hefei, Anhui, China, 230601
- Recruiting
- The Second Hospital of Anhui Medical University
-
Contact:
- Fanfan Li, Site 1003
- Phone Number: +8613855137365
-
-
BEI
-
Beijing, BEI, China, 100021
- Recruiting
- Cancer Hospital Chinese Academy of Medical Sciences
-
Contact:
- Binghe Xu, Site 1001
- Phone Number: +86 13501028690
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100142
- Recruiting
- Beijing Cancer Hospital
-
Contact:
- Huiping Li, Site 1005
- Phone Number: 8613811012595
-
Beijing, Beijing Municipality, China, 100142
- Recruiting
- China-Japan Friendship Hospital
-
Contact:
- Donggui Wan, Site 1024
- Phone Number: 8619854715414
-
-
Fujian
-
Fuzhou, Fujian, China, 350000
- Recruiting
- Fujian Cancer Hospital
-
Contact:
- Fan Wu, Site 1006
- Phone Number: 8613859082118
-
Fyzhou, Fujian, China, 350001
- Recruiting
- Fujian Medical University Union Hospital
-
Contact:
- Fangmeng Fu, Site 1007
- Phone Number: 8613365917923
-
Xiamen, Fujian, China, 361003
- Withdrawn
- Local Institution - 1016
-
-
Gansu
-
Lanzhou, Gansu, China, 730000
- Recruiting
- The First Hospital of Lanzhou University
-
Contact:
- Xiaoling Ling, Site 1031
- Phone Number: 8618693165668
-
-
Guangxi
-
Nanning, Guangxi, China, 530021
- Recruiting
- Guangxi Medical University Affiliated Cancer Hospital
-
Contact:
- Wei Wei, Site 1008
- Phone Number: 8618577071966
-
-
HUN
-
Changsha, HUN, China, 410013
- Not yet recruiting
- Local Institution - 1011
-
Contact:
- Site 1011
-
-
Harbin
-
Harbin, Harbin, China, 150001
- Recruiting
- The First Hospital of harbin University
-
Contact:
- Li Cai, Site 1028
- Phone Number: 8613313602929
-
-
Henan
-
Anyang, Henan, China, 455110
- Recruiting
- Anyang Cancer Hospital
-
Contact:
- Junlan Guo, Site 1004
- Phone Number: 8615037272967
-
Zhengzhou, Henan, China, 450008
- Recruiting
- Henan Cancer Hospital
-
Contact:
- Min Yan, Site 1009
- Phone Number: 8615713857388
-
Zhengzhou, Henan, China, 450052
- Recruiting
- The First Affiliated Hospital of Zhengzhou University
-
Contact:
- Wei He, Site 1032
- Phone Number: +8618638553286
-
-
Hubei
-
Wuhan, Hubei, China, 430070
- Recruiting
- Hubei Cancer Hospital
-
Contact:
- Xinhong Wu, Site 1010
- Phone Number: 8618602726300
-
Wuhan, Hubei, China, 430061
- Recruiting
- Zhongnan Hospital of Wuhan University
-
Contact:
- Haijun Yu, Site 1021
- Phone Number: 8613971665181
-
Xiangyang, Hubei, China, 441000
- Recruiting
- Xiangyang Central Hospital
-
Contact:
- Yuehua Wang, Site 1022
- Phone Number: 8613995777482
-
-
Jiangxi
-
Nanchang, Jiangxi, China, 330029
- Recruiting
- Jiangxi Cancer Hospital
-
Contact:
- Zhengkui Sun, Site 1013
- Phone Number: 8613907000210
-
-
Liaoning
-
Changchun, Liaoning, China, 130021
- Not yet recruiting
- Local Institution - 1012
-
Contact:
- Site 1012
-
Shenyang, Liaoning, China, 140001
- Recruiting
- Liaoning Cancer Hospital
-
Contact:
- Tao Sun, Site 1014
- Phone Number: 8613940404526
-
-
Shandong
-
Jinan, Shandong, China, 250117
- Recruiting
- Cancer Hospital of Shandong First Medical University
-
Contact:
- Huihui Li, Site 1017
- Phone Number: 8615553103209
-
Qingdao, Shandong, China, 266071
- Recruiting
- The Affiliated Hospital Of Qingdao University
-
Contact:
- Haibo Wang, Site 1015
- Phone Number: 8618661805787
-
-
Shanxi
-
Taiyuan, Shanxi, China, 650118
- Recruiting
- Shanxi Cancer Hospital
-
Contact:
- Guohui Han, Site 1018
- Phone Number: 8613454858188
-
-
Sichuan
-
Chengdu, Sichuan, China, 610072
- Recruiting
- Sichuan Provincial People'S Hospital
-
Contact:
- Jing Luo, Site 1019
- Phone Number: 8618981838521
-
-
Tianjin Municipality
-
Tianjin, Tianjin Municipality, China, 300060
- Recruiting
- Tianjin Cancer Hospital Airport Hospital
-
Contact:
- Chunfang Hao, Site 1027
- Phone Number: 8613602031629
-
Tianjin, Tianjin Municipality, China, 301000
- Recruiting
- Tianjin Medical University Cancer Institute & Hospital
-
Contact:
- Yehui Shi, Site 1020
- Phone Number: 8618622221183
-
-
Yunnan
-
Kunming, Yunnan, China, 650118
- Recruiting
- Yunnan Cancer Hospital
-
Contact:
- Guojun Zhang, Site 1029
- Phone Number: 8618850064298
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310024
- Recruiting
- The First Affiliated Hospital, Zhejiang University School of Medicine
-
Contact:
- Peifen Fu, Site 1023
- Phone Number: 8613958161556
-
Hangzhou, Zhejiang, China, 310022
- Not yet recruiting
- Local Institution - 1040
-
Contact:
- Site 1040
-
-
-
-
-
Medellín, Colombia, 050030
- Not yet recruiting
- Local Institution - 0349
-
Contact:
- Site 0349
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 50021
- Withdrawn
- Local Institution - 0195
-
Rionegro, Antioquia, Colombia, 054047
- Not yet recruiting
- Local Institution - 0201
-
Contact:
- Site 0201
-
-
Atlántico
-
Barranquilla, Atlántico, Colombia, 080020
- Not yet recruiting
- Local Institution - 0194
-
Contact:
- Site 0194
-
Puerto Colombia, Atlántico, Colombia, 81001
- Withdrawn
- Local Institution - 0182
-
-
COR
-
Montería, COR, Colombia, 230002
- Not yet recruiting
- Local Institution - 0181
-
Contact:
- Site 0181
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colombia, 111151
- Not yet recruiting
- Local Institution - 0327
-
Contact:
- Site 0327
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Colombia, 760032
- Not yet recruiting
- Local Institution - 0183
-
Contact:
- Site 0183
-
-
-
-
-
Lille, France, 59000
- Completed
- Local Institution - 0094
-
Paris, France, 75248
- Withdrawn
- Local Institution - 0088
-
-
Aquitaine
-
Bordeaux, Aquitaine, France, 33076
- Active, not recruiting
- Local Institution - 0089
-
-
Auvergne-Rhône-Alpes
-
Lyon, Auvergne-Rhône-Alpes, France, 69008
- Withdrawn
- Local Institution - 0090
-
-
Côte-d'Or
-
Dijon, Côte-d'Or, France, 21079
- Completed
- Local Institution - 0272
-
-
Haute-Garonne
-
Toulouse, Haute-Garonne, France, 31059
- Withdrawn
- Local Institution - 0098
-
-
Hérault
-
Montpellier, Hérault, France, 34298
- Recruiting
- Institut Régional du Cancer Montpellier
-
Contact:
- Marie Alexandre, Site 0095
- Phone Number: 33467612393
-
-
Ille-et-Vilaine
-
Rennes, Ille-et-Vilaine, France, 35042
- Completed
- Local Institution - 0099
-
-
Loire-Atlantique
-
Saint-Herblain, Loire-Atlantique, France, 44805
- Completed
- Local Institution - 0092
-
-
Marne
-
Reims, Marne, France, 51726
- Withdrawn
- Local Institution - 0091
-
-
Paris
-
Villejuif, Paris, France, 94800
- Active, not recruiting
- Local Institution - 0097
-
-
Provence-Alpes-Côte d'Azur Region
-
Marseille, Provence-Alpes-Côte d'Azur Region, France, 13273
- Recruiting
- Institut Paoli-Calmettes
-
Contact:
- Alexandre Tassin de Nonneville, Site 0093
- Phone Number: 0033621713044
-
-
Puy-de-Dôme
-
Clermont-Ferrand, Puy-de-Dôme, France, 63011
- Recruiting
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
-
Contact:
- Olivier Collard, Site 0096
- Phone Number: 33473278005
-
-
Vienne
-
Poitiers, Vienne, France, 86021
- Withdrawn
- Local Institution - 1033
-
-
-
-
-
Berlin, Germany, 10117
- Active, not recruiting
- Local Institution - 0261
-
Berlin, Germany, 10967
- Active, not recruiting
- Local Institution - 0260
-
Bonn, Germany, 53111
- Active, not recruiting
- Local Institution - 0259
-
Dresden, Germany, 01307
- Active, not recruiting
- Local Institution - 0258
-
Heidelberg, Germany, D-69120
- Active, not recruiting
- Local Institution - 0262
-
Ulm, Germany, 89081
- Active, not recruiting
- Local Institution - 0291
-
-
Baden-Wurttemberg
-
Esslingen am Neckar, Baden-Wurttemberg, Germany, 73730
- Active, not recruiting
- Local Institution - 0320
-
-
Bavaria
-
Augsburg, Bavaria, Germany, 86156
- Active, not recruiting
- Local Institution - 0256
-
München, Bavaria, Germany, 80637
- Active, not recruiting
- Local Institution - 0271
-
-
Hesse
-
Frankfurt am Main, Hesse, Germany, 60590
- Active, not recruiting
- Local Institution - 0306
-
Langen, Hesse, Germany, 63225
- Active, not recruiting
- Local Institution - 0333
-
-
Lower Saxony
-
Hanover, Lower Saxony, Germany, 30625
- Active, not recruiting
- Local Institution - 0257
-
-
North Rhine-Westphalia
-
Düsseldorf, North Rhine-Westphalia, Germany, 40235
- Completed
- Local Institution - 0293
-
Essen, North Rhine-Westphalia, Germany, 45136
- Active, not recruiting
- Local Institution - 0263
-
-
Saxony
-
Leipzig, Saxony, Germany, 04103
- Not yet recruiting
- Local Institution - 0254
-
Contact:
- Site 0254
-
-
Schleswig-Holstein
-
Lübeck, Schleswig-Holstein, Germany, 23538
- Completed
- Local Institution - 0255
-
-
-
-
Attica
-
Athens, Attica, Greece, 11528
- Withdrawn
- Local Institution - 0043
-
-
Attikí
-
Athens, Attikí, Greece, 115 22
- Active, not recruiting
- Local Institution - 0042
-
Athens, Attikí, Greece, 185 47
- Completed
- Local Institution - 0038
-
-
Irakleío
-
Heraklion, Irakleío, Greece, 715 00
- Completed
- Local Institution - 0086
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400 057
- Withdrawn
- Local Institution - 0337
-
Mumbai, Maharashtra, India, 400012
- Withdrawn
- Local Institution - 0131
-
Nagpur, Maharashtra, India, 440001
- Withdrawn
- Local Institution - 0134
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, India, 110017
- Withdrawn
- Local Institution - 0352
-
New Delhi, National Capital Territory of Delhi, India, 110029
- Withdrawn
- Local Institution - 0266
-
New Delhi, National Capital Territory of Delhi, India, 110085
- Withdrawn
- Local Institution - 0206
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600035
- Withdrawn
- Local Institution - 0125
-
-
Telangana
-
Hyderabad, Telangana, India, 500082
- Withdrawn
- Local Institution - 0130
-
-
Uttar Pradesh
-
Varanasi, Uttar Pradesh, India, 221005
- Withdrawn
- Local Institution - 0133
-
-
-
-
Central District
-
Petah Tikva, Central District, Israel, 4941492
- Not yet recruiting
- Local Institution - 0186
-
Contact:
- Site 0186
-
Ramat Gan, Central District, Israel, 5265601
- Active, not recruiting
- Local Institution - 0044
-
-
Jerusalem
-
Jerusalem, Jerusalem, Israel, 9112001
- Completed
- Local Institution - 0047
-
-
Northern District
-
Hadera, Northern District, Israel, 38100
- Active, not recruiting
- Local Institution - 0048
-
Haifa, Northern District, Israel, 3109601
- Active, not recruiting
- Local Institution - 0123
-
-
-
-
-
Milan, Italy, 20141
- Active, not recruiting
- Local Institution - 0052
-
Naples, Italy, 80131
- Completed
- Local Institution - 0058
-
Novara, Italy, 28100
- Completed
- Local Institution - 0061
-
Padova, Italy, 35128
- Completed
- Local Institution - 0056
-
Roma, Italy, 00168
- Active, not recruiting
- Local Institution - 0062
-
-
Campania
-
Naples, Campania, Italy, 80131
- Active, not recruiting
- Local Institution - 0051
-
-
Emilia-Romagna
-
Bologna, Emilia-Romagna, Italy, 40138
- Completed
- Local Institution - 0049
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, Italy, 33081
- Active, not recruiting
- Local Institution - 0057
-
-
Liguria
-
Genoa, Liguria, Italy, 16132
- Completed
- Local Institution - 0054
-
-
Pisa
-
Pontedera, Pisa, Italy, 56025
- Active, not recruiting
- Local Institution - 0053
-
-
Tuscany
-
Prato, Tuscany, Italy, 59100
- Completed
- Local Institution - 0055
-
-
-
-
-
Fukuoka, Japan, 811-1395
- Withdrawn
- Local Institution - 0242
-
Fukushima, Japan, 960-1295
- Withdrawn
- Local Institution - 0225
-
Hiroshima, Japan, 7308518
- Withdrawn
- Local Institution - 0243
-
Kyoto, Japan, 606-8507
- Withdrawn
- Local Institution - 0235
-
Okayama, Japan, 700-8558
- Withdrawn
- Local Institution - 0241
-
Osaka, Japan, 541-8567
- Withdrawn
- Local Institution - 0239
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japan, 464-8681
- Withdrawn
- Local Institution - 0236
-
-
Chiba
-
Chiba, Chiba, Japan, 260-8717
- Withdrawn
- Local Institution - 0230
-
-
Ehime
-
Matsuyama, Ehime, Japan, 791-0280
- Withdrawn
- Local Institution - 0240
-
-
Gunma
-
Otashi, Gunma, Japan, 373-8550
- Withdrawn
- Local Institution - 0226
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 003-0804
- Withdrawn
- Local Institution - 0222
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japan, 920-8530
- Withdrawn
- Local Institution - 0232
-
-
Kagoshima-ken
-
Kagoshima, Kagoshima-ken, Japan, 892-0833
- Withdrawn
- Local Institution - 0244
-
-
Kanagawa
-
Isehara, Kanagawa, Japan, 259-1193
- Withdrawn
- Local Institution - 0234
-
Yokohama, Kanagawa, Japan, 2418515
- Withdrawn
- Local Institution - 0237
-
-
Mie-ken
-
Tsu, Mie-ken, Japan, 514-8507
- Withdrawn
- Local Institution - 0246
-
-
Miyagi
-
Sendai, Miyagi, Japan, 980-8574
- Withdrawn
- Local Institution - 0223
-
-
Osaka
-
Suita, Osaka, Japan, 565-0871
- Withdrawn
- Local Institution - 0238
-
-
Saitama
-
Hidaka, Saitama, Japan, 350-1298
- Withdrawn
- Local Institution - 0227
-
Ina-machi, Saitama, Japan, 362-0806
- Withdrawn
- Local Institution - 0224
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan, 113-8431
- Withdrawn
- Local Institution - 0231
-
Chuo-ku, Tokyo, Japan, 104-0045
- Withdrawn
- Local Institution - 0229
-
Koto, Tokyo, Japan, 135-8550
- Withdrawn
- Local Institution - 0228
-
Shinagawa-ku, Tokyo, Japan, 142-8666
- Withdrawn
- Local Institution - 0245
-
Shinjuku-ku, Tokyo, Japan, 160-0023
- Withdrawn
- Local Institution - 0233
-
-
-
-
-
Chihuahua City, Mexico, 31207
- Recruiting
- Scientia Investigacion Clinica S.C.
-
Contact:
- Enrique Zamudio Lozoya, Site 0174
- Phone Number: 6146883416
-
-
DIF
-
Mexico City, DIF, Mexico, 03100
- Recruiting
- CENEIT Oncologicos
-
Contact:
- Alberto Suarez Zaizar, Site 0177
- Phone Number: 525555342400
-
-
Estado de Baja California
-
Tijuana, Estado de Baja California, Mexico, 22010
- Not yet recruiting
- Local Institution - 0264
-
Contact:
- Site 0264
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44680
- Not yet recruiting
- Local Institution - 0178
-
Contact:
- Site 0178
-
-
Mexico City
-
Mexico City, Mexico City, Mexico, 14070
- Not yet recruiting
- Local Institution - 0329
-
Contact:
- Site 0329
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexico, 64320
- Not yet recruiting
- Local Institution - 0175
-
Contact:
- Site 0175
-
Monterrey, Nuevo León, Mexico, 64460
- Not yet recruiting
- Local Institution - 0176
-
Contact:
- Site 0176
-
Monterrey, Nuevo León, Mexico, 64460
- Withdrawn
- Local Institution - 0355
-
-
Oaxaca
-
Oaxaca City, Oaxaca, Mexico, 68020
- Not yet recruiting
- Local Institution - 0173
-
Contact:
- Site 0173
-
-
Yucatán
-
Mérida, Yucatán, Mexico, 97000
- Not yet recruiting
- Local Institution - 0179
-
Contact:
- Site 0179
-
-
-
-
Greater Poland Voivodeship
-
Skórzewo, Greater Poland Voivodeship, Poland, 60-185
- Active, not recruiting
- Local Institution - 0189
-
-
Lublin Voivodeship
-
Biała Podlaska, Lublin Voivodeship, Poland, 21-500
- Withdrawn
- Local Institution - 0074
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Poland, 02-781
- Not yet recruiting
- Local Institution - 0072
-
Contact:
- Site 0072
-
Warsaw, Masovian Voivodeship, Poland, 03-411
- Active, not recruiting
- Local Institution - 0220
-
-
Opole Voivodeship
-
Opole, Opole Voivodeship, Poland, 45-061
- Not yet recruiting
- Local Institution - 0076
-
Contact:
- Site 0076
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Poland, 93-338
- Active, not recruiting
- Local Institution - 0221
-
-
-
-
-
Coimbra, Portugal, 3000-075
- Recruiting
- Instituto Portugês de Oncologia de Coimbra Francisco Gentil
-
Contact:
- Gabriela Sousa, Site 0124
- Phone Number: +351239400200
-
Lisbon, Portugal, 1500-650
- Recruiting
- Hospital da Luz Lisboa
-
Contact:
- Catarina Pulido, Site 0141
- Phone Number: +351917187738
-
Porto, Portugal, 4200-072
- Recruiting
- Instituto Português de Oncologia do Porto Francisco Gentil, EPE
-
Contact:
- Cristina Oliveira, Site 0111
-
Porto, Portugal, 4200-319
- Recruiting
- Centro Hospitalar de Sao Joao - Hospital de Sao Joao
-
Contact:
- Isabel Augusto, Site 0253
- Phone Number: +351963903409
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1649-035
- Recruiting
- Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria
-
Contact:
- Luis Costa, Site 0109
- Phone Number: 351217805257
-
Lisbon, Lisbon District, Portugal, 1400-038
- Not yet recruiting
- Local Institution - 0106
-
Contact:
- Site 0106
-
Lisbon, Lisbon District, Portugal, 1099-023
- Recruiting
- Instituto Português de Oncologia de Lisboa Francisco Gentil
-
Contact:
- Patricia Pereira, Site 0198
-
-
-
-
-
Bucharest, Romania, 011171
- Active, not recruiting
- Local Institution - 0083
-
Cluj-Napoca, Romania, 400015
- Active, not recruiting
- Local Institution - 0077
-
Dumbrăviţa, Romania, 307160
- Completed
- Local Institution - 0211
-
Iași, Romania, 700106
- Active, not recruiting
- Local Institution - 0081
-
Iași, Romania, 700483
- Completed
- Local Institution - 0080
-
Ploieşti, Romania, 100337
- Active, not recruiting
- Local Institution - 0084
-
-
Bistrița-Năsăud County
-
Bistriţa, Bistrița-Năsăud County, Romania, 420020
- Not yet recruiting
- Local Institution - 0212
-
Contact:
- Site 0212
-
-
Bucharest
-
Bucharest, Bucharest, Romania, 012292
- Completed
- Local Institution - 0213
-
-
Cluj
-
Florești, Cluj, Romania, 407280
- Active, not recruiting
- Local Institution - 0079
-
-
Dolj
-
Craiova, Dolj, Romania, 200746
- Completed
- Local Institution - 0078
-
-
Timiș County
-
Timișoara, Timiș County, Romania, 300239
- Active, not recruiting
- Local Institution - 0085
-
-
-
-
-
Johannesburg, South Africa, 2193
- Withdrawn
- Local Institution - 0342
-
Pretoria, South Africa, 0001
- Withdrawn
- Local Institution - 0336
-
Pretoria, South Africa, 0084
- Withdrawn
- Local Institution - 0341
-
Soweto, South Africa, 2013
- Withdrawn
- Local Institution - 0340
-
-
Eastern Cape
-
East London, Eastern Cape, South Africa, 5241
- Not yet recruiting
- Local Institution - 0351
-
Contact:
- Site 0351
-
-
Western Cape
-
Cape Town, Western Cape, South Africa, 7570
- Withdrawn
- Local Institution - 1034
-
-
-
-
Kyǒnggi-do
-
Goyang-si, Kyǒnggi-do, South Korea, 10408
- Not yet recruiting
- Local Institution - 0066
-
Contact:
- Site 0066
-
Seongnam, Kyǒnggi-do, South Korea, 13620
- Not yet recruiting
- Local Institution - 0067
-
Contact:
- Site 0067
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 02841
- Not yet recruiting
- Local Institution - 0068
-
Contact:
- Site 0068
-
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 03080
- Not yet recruiting
- Local Institution - 0063
-
Contact:
- Site 0063
-
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 03722
- Not yet recruiting
- Local Institution - 0071
-
Contact:
- Site 0071
-
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 05505
- Not yet recruiting
- Local Institution - 0064
-
Contact:
- Site 0064
-
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 06351
- Not yet recruiting
- Local Institution - 0065
-
Contact:
- Site 0065
-
-
Taegu-Kwangyǒkshi
-
Daegu, Taegu-Kwangyǒkshi, South Korea, 41404
- Not yet recruiting
- Local Institution - 0069
-
Contact:
- Site 0069
-
-
-
-
-
Madrid, Spain, 28007
- Completed
- Local Institution - 0107
-
Seville, Spain, 41009
- Recruiting
- Hospital Universitario Virgen Macarena
-
Contact:
- Luis de la Cruz Merino, Site 0103
- Phone Number: +34955926578
-
-
A Coruña [La Coruña]
-
A Coruña, A Coruña [La Coruña], Spain, 15006
- Recruiting
- CHUAC-Hospital Teresa Herrera
-
Contact:
- Silvia Antolin Novoa, Site 0105
- Phone Number: +34981178000
-
-
Alicante
-
Elche, Alicante, Spain, 03203
- Recruiting
- Hospital General Universitario de Elche
-
Contact:
- Álvaro Rodríguez-Lescure, Site 0100
- Phone Number: 111-111-1111
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], Spain, 08035
- Recruiting
- Hospital Universitari Vall d'Hebron
-
Contact:
- Ana Mafalda Antunes de Melo e Oliveira, Site 0102
- Phone Number: 34934894158
-
Hospitalet, Barcelona [Barcelona], Spain, 08907
- Completed
- Local Institution - 0172
-
-
Catalunya [Cataluña]
-
Barcelona, Catalunya [Cataluña], Spain, 08036
- Recruiting
- Hospital Clínic de Barcelona
-
Contact:
- Marta González Rodríguez, Site 0140
- Phone Number: +34606895621
-
-
Gipuzkoa
-
Donostia / San Sebastian, Gipuzkoa, Spain, 20014
- Recruiting
- Hospital Universitario Donostia
-
Contact:
- Isabel Alvarez Lopez, Site 0139
- Phone Number: 34943006002
-
-
Madrid, Comunidad de
-
Madrid, Madrid, Comunidad de, Spain, 28009
- Recruiting
- Hospital General Universitario Gregorio Marañon
-
Contact:
- Sara Lopez Tarruella, Site 0104
- Phone Number: 34914269392
-
Madrid, Madrid, Comunidad de, Spain, 28041
- Completed
- Local Institution - 0108
-
-
Málaga
-
Málaga, Málaga, Spain, 29010
- Recruiting
- Hospital Universitario Virgen de la Victoria
-
Contact:
- Maria Emilia Dominguez Recio, Site 0101
- Phone Number: 34951291425
-
-
Valenciana, Comunitat
-
Valencia, Valenciana, Comunitat, Spain, 46010
- Recruiting
- Hospital Clinico de Valencia
-
Contact:
- Begona Bermejo de las Heras, Site 0210
- Phone Number: 34961973583
-
-
-
-
Skåne Län [se-12]
-
Malmö, Skåne Län [se-12], Sweden, 205 02
- Active, not recruiting
- Local Institution - 0252
-
-
Stockholms Län [se-01]
-
Stockholm, Stockholms Län [se-01], Sweden, 112 19
- Active, not recruiting
- Local Institution - 0026
-
-
Uppsala Län [se-03]
-
Uppsala, Uppsala Län [se-03], Sweden, 751 85
- Active, not recruiting
- Local Institution - 0025
-
-
Örebro Län [se-18]
-
Örebro, Örebro Län [se-18], Sweden, 701 85
- Active, not recruiting
- Local Institution - 0024
-
-
Östergötlands Län [se-05]
-
Linköping, Östergötlands Län [se-05], Sweden, 581 85
- Active, not recruiting
- Local Institution - 0247
-
-
-
-
-
Zurich, Switzerland, 8008
- Active, not recruiting
- Local Institution - 0251
-
-
Canton of St. Gallen
-
Sankt Gallen, Canton of St. Gallen, Switzerland, 9007
- Active, not recruiting
- Local Institution - 0250
-
-
Canton of Vaud
-
Lausanne, Canton of Vaud, Switzerland, 1011
- Active, not recruiting
- Local Institution - 0249
-
-
-
-
-
Adana, Turkey (Türkiye), 01123
- Not yet recruiting
- Local Institution - 0361
-
Contact:
- Site 0361
-
Ankara, Turkey (Türkiye), 06800
- Not yet recruiting
- Local Institution - 0362
-
Contact:
- Site 0362
-
Istanbul, Turkey (Türkiye), 34722
- Not yet recruiting
- Local Institution - 0363
-
Contact:
- Site 0363
-
Istanbul, Turkey (Türkiye), 34010
- Not yet recruiting
- Local Institution - 0364
-
Contact:
- Site 0364
-
-
-
-
-
Abu Dhabi, United Arab Emirates
- Withdrawn
- Local Institution - 0319
-
-
Abu Dhabi Emirate
-
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 11001
- Withdrawn
- Local Institution - 0323
-
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 92510
- Withdrawn
- Local Institution - 0318
-
Al Ain City, Abu Dhabi Emirate, United Arab Emirates, 15258
- Withdrawn
- Local Institution - 0322
-
-
-
-
-
Belfast, United Kingdom, BT9 7AB
- Withdrawn
- Local Institution - 0171
-
Manchester, United Kingdom, M20 4BX
- Active, not recruiting
- Local Institution - 0001
-
Nottingham, United Kingdom, NG5 1PB
- Not yet recruiting
- Local Institution - 0006
-
Contact:
- Site 0006
-
-
England
-
Truro, England, United Kingdom, TR1 3LJ
- Completed
- Local Institution - 0208
-
-
London, City of
-
London, London, City of, United Kingdom, SE1 9RT
- Withdrawn
- Local Institution - 0204
-
London, London, City of, United Kingdom, EC1A 7BE
- Active, not recruiting
- Local Institution - 0004
-
London, London, City of, United Kingdom, SE1 9RT
- Completed
- Local Institution - 0209
-
-
-
-
Arkansas
-
Hot Springs, Arkansas, United States, 71913
- Not yet recruiting
- Local Institution - 0303
-
Contact:
- Site 0303
-
-
California
-
Cerritos, California, United States, 90703
- Withdrawn
- Local Institution - 0307
-
Cerritos, California, United States, 90703
- Withdrawn
- Local Institution - 0308
-
Cerritos, California, United States, 90703
- Withdrawn
- Local Institution - 0309
-
Cerritos, California, United States, 90703
- Active, not recruiting
- Local Institution - 0328
-
Long Beach, California, United States, 90805
- Withdrawn
- Local Institution - 0311
-
Los Angeles, California, United States, 90033
- Completed
- Local Institution - 0290
-
Los Angeles, California, United States, 90067
- Completed
- Local Institution - 0283
-
Newport Beach, California, United States, 92663
- Completed
- Local Institution - 0353
-
Stanford, California, United States, 94305
- Withdrawn
- Local Institution - 0358
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Not yet recruiting
- Local Institution - 0289
-
Contact:
- Site 0289
-
Denver, Colorado, United States, 80220
- Active, not recruiting
- Local Institution - 0367
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Completed
- Local Institution - 0304
-
-
Florida
-
Pembroke Pines, Florida, United States, 33028
- Withdrawn
- Local Institution - 0296
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Completed
- Local Institution - 0294
-
Atlanta, Georgia, United States, 30342
- Completed
- Local Institution - 0357
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- Not yet recruiting
- Local Institution - 0280
-
Contact:
- Site 0280
-
Chicago, Illinois, United States, 60612
- Withdrawn
- Local Institution - 0278
-
Decatur, Illinois, United States, 62526
- Completed
- Local Institution - 0275
-
O'Fallon, Illinois, United States, 62269
- Withdrawn
- Local Institution - 0324
-
-
Louisiana
-
Covington, Louisiana, United States, 70433
- Completed
- Local Institution - 0286
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Withdrawn
- Local Institution - 1035
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Completed
- Local Institution - 0288
-
Boston, Massachusetts, United States, 02215
- Active, not recruiting
- Local Institution - 0287
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Completed
- Local Institution - 0359
-
-
Minnesota
-
Maple Grove, Minnesota, United States, 55369
- Completed
- Local Institution - 0313
-
Minneapolis, Minnesota, United States, 55455
- Withdrawn
- Local Institution - 0372
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Completed
- Local Institution - 0284
-
-
New York
-
New York, New York, United States, 10016
- Withdrawn
- Local Institution - 0312
-
New York, New York, United States, 10065
- Completed
- Local Institution - 0279
-
Syracuse, New York, United States, 13210
- Withdrawn
- Local Institution - 1037
-
Westbury, New York, United States, 11590
- Completed
- Local Institution - 0295
-
White Plains, New York, United States, 10601
- Completed
- Local Institution - 0285
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Completed
- Local Institution - 0276
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Completed
- Local Institution - 0316
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18103
- Active, not recruiting
- Local Institution - 0356
-
Philadelphia, Pennsylvania, United States, 19104
- Completed
- Local Institution - 0310
-
Pittsburgh, Pennsylvania, United States, 15213-3403
- Withdrawn
- Local Institution - 0360
-
-
South Carolina
-
Greenville, South Carolina, United States, 29607
- Completed
- Local Institution - 0281
-
-
Texas
-
Austin, Texas, United States, 78705
- Completed
- Local Institution - 0315
-
El Paso, Texas, United States, 79902
- Completed
- Local Institution - 0368
-
Flower Mound, Texas, United States, 75028
- Active, not recruiting
- Local Institution - 0305
-
Houston, Texas, United States, 77024-2843
- Completed
- Local Institution - 0314
-
-
Virginia
-
Midlothian, Virginia, United States, 23114
- Active, not recruiting
- Local Institution - 0277
-
Roanoke, Virginia, United States, 24014
- Not yet recruiting
- Local Institution - 0301
-
Contact:
- Site 0301
-
Winchester, Virginia, United States, 22601
- Active, not recruiting
- Local Institution - 0302
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
-
Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic triple-negative breast cancer (TNBC) (ER < 1%, PgR < 1%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) per American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, based on the most recently analyzed biopsy or other pathology specimen.
-
Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
-
Participants with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 (eg, pembrolizumab) or an anti-PD-L1 (eg, atezolizumab) due to any one of the following criteria:
i) Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of standard of care (SoC); ii) Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1; iii) Has a severe auto-immune disease or other contraindication, in the opinion of the investigator, for the use of an anti-PD(L)1 drug: iv) Any auto-immune disease that requires current immunosuppression (eg, methotrexate, cyclophosphamide, prednisone > 10 mg/day).
v) Prior auto-immune AE to peri-adjuvant ICI that required immunosuppression. vi) Current Graves' disease with ophthalmopathy or in need of radioiodine or in use of antithyroid medication.
vii) Current or prior auto-immune diseases per below: A. Moderate to severe rheumatoid arthritis. B. Auto-immune hepatitis or cholangitis. C. Myasthenia gravis. D. Moderate-to-severe or poorly controlled inflammatory bowel disease. E. Multiple sclerosis. F. Lupus with kidney involvement or moderate to severe lupus. G. Auto-immune myocarditis. Note: if participant meets Inclusion Criteria 5b or 5c, unknown PDL1 results per local SOC are acceptable in these specific cases.
- Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
- No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
- Measurable disease by CT or MRI as per RECIST v1.1.
Exclusion Criteria
-
Participants with a known germline breast cancer gene (BRCA) 1 or 2 mutation whose best 1L treatment option, in the opinion of the investigator, is a poli-ADP-ribose-polymerase inhibitors (PARPi).
-
Untreated symptomatic central nervous system (CNS) metastases. Participants are eligible if CNS metastases have been treated, and participants' neurological signs and symptoms have returned to baseline. In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least 2 weeks prior to randomization. Imaging performed within 28 days of randomization must document radiographic stability of CNS lesions and be performed after completion of any CNS directed therapy.
-
Leptomeningeal metastases.
-
Participants with history of severe heart disease including, but not limited to, any of the following:
i) History of clinically significant heart disease (eg, cardiomyopathy, congestive heart failure with New York Heart Association functional classification II to IV, pericarditis, or significant pericardial effusion).
ii) Myocardial infarction, uncontrolled angina, or stroke/transient ischemic attack within the past 6 months.
iii) QTc (by Fridericia's formula) prolongation ≥ 450 msec for males and ≥ 470 msec for females, except for right bundle branch block.
iv) Known LVEF < 50%.
- Prior therapy with iza-bren or any other ADC targeting EGFR and/or HER3 or containing a topoisomerase 1 inhibitor payload.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Arm B
|
Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days |
|
Experimental: Arm A1
|
Specified dose on specified days
Other Names:
|
|
Experimental: Arm A2
|
Specified dose on specified days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recommended Phase 3 Dose (RP3D) of BMS-986507
Time Frame: Approximately 13 months from first participant randomization in Phase 2
|
Approximately 13 months from first participant randomization in Phase 2
|
|
|
Progression-Free Survival (PFS)
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by blinded independent central review (BICR) |
Approximately 22 months from first participant randomization in Phase 3
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Survival (OS)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with treatment-related Adverse Events (AEs)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with laboratory abnormalities
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with serious AEs (SAEs)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with AEs leading to treatment discontinuation, interruption, dose reduction or dose delay
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of deaths
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per BICR
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per Investigator
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Relative change in tumor size
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per BICR
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per Investigator
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of Response (DOR) per BICR
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of response (DOR) per Investigator
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to Response (TTR) per BICR
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to response (TTR) per Investigator
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in EORTC Breast Cancer-specific Quality of Life Questionnaire (QLQ-BR23)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Functional Assessment of Chronic Illness Therapy item GP5 (FACIT GP5) score
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5L)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
PFS rate
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by BICR |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS rate
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS
Time Frame: Approximately 22 months from first participant randomization in Phase 3
|
Assessed by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
Time to subsequent treatment (TTST) per Investigator
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as time from randomization to the start of subsequent therapy or death |
Approximately up to 47 months from first participant randomization in Phase 3
|
|
Progression-free survival after next line of treatment (PFS2)
Time Frame: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as the time from randomization to the date of investigator-defined documented disease progression after next line of treatment or death due to any cause, whichever comes first |
Approximately up to 47 months from first participant randomization in Phase 3
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Skin Diseases
- Breast Diseases
- Skin and Connective Tissue Diseases
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Organic Chemicals
- Heterocyclic Compounds, 1-Ring
- Heterocyclic Compounds
- Nucleic Acids, Nucleotides, and Nucleosides
- Hydrocarbons
- Cycloparaffins
- Hydrocarbons, Alicyclic
- Hydrocarbons, Cyclic
- Terpenes
- Coordination Complexes
- Taxoids
- Cyclodecanes
- Diterpenes
- Deoxycytidine
- Cytidine
- Pyrimidine Nucleosides
- Pyrimidines
- Nucleosides
- Uracil
- Pyrimidinones
- Deoxyribonucleosides
- Fluorouracil
- Capecitabine
- Gemcitabine
- Carboplatin
- Paclitaxel
- 130-nm albumin-bound paclitaxel
Other Study ID Numbers
Other Study ID Numbers
- CA244-0008
- 2024-519871-24 (Other Identifier: EU CTR)
- U1111-1316-1533 (Other Identifier: WHO)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
IPD Sharing Time Frame
See Plan Description
IPD Sharing Access Criteria
See Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.